Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study

2016 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study​
Rasche, L.; Heiserich, L.; Behrens, J. R.; Lenz, K.; Pfuhl, C.; Wakonig, K. & Giess, R. M. et al.​ (2016) 
PLoS ONE11(1) art. e0147968​.​ DOI: https://doi.org/10.1371/journal.pone.0147968 

Documents & Media

journal.pone.0147968.pdf831.25 kBAdobe PDF

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Rasche, Ludwig; Heiserich, Lisa; Behrens, Janina Ruth; Lenz, Klaus; Pfuhl, Catherina; Wakonig, Katharina; Giess, Rene Markus; Freitag, Erik; Eberle, Caroline; Wuerfel, Jens; Doerr, Jan; Bauer, Peter; Bellmann-Strobl, Judith; Paul, Friedemann; Roggenbuck, Dirk; Ruprecht, Klemens
Abstract
Background In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as gamma-H2AX. Formation of gamma-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1), a regulator of the cellular response to DNA double-strand breaks. gamma-H2AX expression in peripheral blood mononuclear cells (PBMCs) was recently proposed as a diagnostic and disease activity marker for multiple sclerosis (MS). Objective To evaluate the significance of gamma-H2AX and 53BP1 foci in PBMCs as diagnostic and disease activity markers in patients with clinically isolated syndrome (CIS) and early relapsing-remitting MS (RRMS) using automated. gamma-H2AX and 53BP1 foci detection. Methods Immunocytochemistry was performed on freshly isolated PBMCs of patients with CIS/early RRMS (n = 25) and healthy controls (n = 27) with gamma-H2AX and 53BP1 specific antibodies. Nuclear gamma-H2AX and 53BP1 foci were determined using a fully automated reading system, assessing the numbers of gamma-H2AX and 53BP1 foci per total number of cells and the percentage of cells with foci. Patients underwent contrast enhanced 3 Tesla magnetic resonance imaging (MRI) and clinical examination including expanded disability status scale (EDSS) score. gamma-H2AX and 53BP1 were also compared in previously frozen PBMCs of each 10 CIS/early RRMS patients with and without contrast enhancing lesions (CEL) and 10 healthy controls. Results The median (range) number of gamma-H2AX (0.04 [0-0.5]) and 53BP1 (0.005 [0-0.2]) foci per cell in freshly isolated PBMCs across all study participants was low and similar to previously reported values of healthy individuals. For both, gamma-H2AX and 53BP1, the cellular focus number as well as the percentage of positive cells did not differ between patients with CIS/RRMS and healthy controls. gamma-H2AX and 53BP1 levels neither correlated with number nor volume of T2-weighted lesions on MRI, nor with the EDSS. Although gamma-H2AX, but not 53BP1, levels were higher in previously frozen PBMCs of patients with than without CEL, gamma-H2AX values of both groups overlapped and gamma-H2AX did not correlate with the number or volume of CEL. Conclusion gamma-H2AX and 53BP1 foci do not seem to be promising diagnostic or disease activity biomarkers in patients with early MS. Lymphocytic DNA double-strand breaks are unlikely to play a major role in the pathophysiology of MS.
Issue Date
2016
Status
published
Publisher
Public Library Science
Journal
PLoS ONE 
ISSN
1932-6203

Reference

Citations


Social Media